NICE’s final draft guidance (published Friday 3 May 2024), recommends voxelotor (also called Oxbryta and made by Pfizer) with or without another treatment for SCD called hydroxycarbamide.

Children and teenagers with an aggressive form of brain cancer set to benefit after NICE recommends new life-extending drug ...

Colostomy surgery is an operation to divert 1 or both ends of the colon through an opening in the abdomen (NHS, 2020). A bag (also known as a pouch or appliance) can be placed over the stoma to ...

Robot-assisted surgery (RAS) is a type of minimally invasive surgery. Typically, the surgeon guides the robot into the body through small cuts and does the procedure from a computer console, next to ...

NICE is unable to make a recommendation on pembrolizumab (Keytruda) with gemcitabine and cisplatin for untreated advanced biliary tract cancer in adults. This is because Merck Sharp & Dohme did not ...

Tools to help you put the guidance into practice.

A list of downloadable documents created during development.

Tools to help you put the guidance into practice.

NICE is unable to make a recommendation on melphalan flufenamide (Pepaxti) for treating relapsed or refractory multiple myeloma in adults. This is because Oncopeptides did not provide an evidence ...

You should read both the consultation document and the accompanying evidence (see the committee papers) before making any comments. You must make your comments ...

Suggested remit: To appraise the clinical and cost effectiveness of imlunestrant within its marketing authorisation for treating oestrogen receptor-positive, HER2-negative advanced breast cancer after ...